Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-01-29, Stock:ABBV, The news for the past five days is as follows:
2018-01-22: NEWS1: MTUM, BA, ABBV, MCD: Large Inflows Detected at ETF.NEWS2: 3 Top Stocks Bloggers Are Raving Over Right Now.NEWS3: What's in the Cards for Varian Medical (VAR) in Q1 Earnings?.NEWS4: Will These 4 Large-Cap Drug Stocks Be Big Winners This Earnings Season?.NEWS5: What's in the Cards for Novartis (NVS) This Earnings Season?.NEWS6: Healthcare ETFs to Watch As Q4 Earnings Unfold.NEWS7: What&apos;s in the Cards for Varian Medical (VAR) in Q1 Earnings?.NEWS8: Is Investment in the Marijuana Space Picking Up?.NEWS9: What&apos;s in the Cards for Novartis (NVS) This Earnings Season?.NEWS10: Behind Novartis’s 4Q17 Earnings: Why Some Expect Revenue Growth.NEWS11: The Motivation for Recreational Marijuana Consumption.NEWS12: Will These 4 Large-Cap Drug Stocks Be Big Winners This Earnings Season?.NEWS13: Why the Medical Marijuana Industry Is Growing.NEWS14: Merck & Co.’s Cardiovascular and Immunology Products in 3Q17.
2018-01-23: NEWS1: Novartis Announces Positive Results on Migraine Candidate.NEWS2: 3 Large Cap Pharma Stocks to Beat Earnings This Quarter.NEWS3: Vermont Legalizes Recreational Marijuana on January 22, 2018.NEWS4: 3 Large Cap Pharma Stocks to Beat Earnings This Quarter.NEWS5: Stocks Showing Improving Market Leadership: Grifols Earns 82 RS Rating.NEWS6: J&J (JNJ) Q4 Earnings Top, Pharma Sales Continue to Improve.NEWS7: The Other Side of Legalizing Recreational Marijuana.NEWS8: J&J (JNJ) Q4 Earnings Top, Pharma Sales Continue to Improve.NEWS9: The Zacks Analyst Blog Highlights: Alexion Pharmaceuticals, Celgene, AbbVie and Merck.NEWS10: What a Country Could Gain from Legalizing Recreational Marijuana.NEWS11: The Zacks Analyst Blog Highlights: Alexion Pharmaceuticals, Celgene, AbbVie and Merck.NEWS12: The Marijuana Ecosystem’s Potential Business Opportunities.NEWS13: Analyst Recommendations for Merck & Co. in January 2018.
2018-01-24: NEWS1: Is a Beat in the Cards for AbbVie (ABBV) in Q4 Earnings?.NEWS2: 3 Stocks to Help You Build Retirement Wealth.NEWS3: See Which Of The Latest 13F Filers Holds AbbVie.NEWS4: The Zacks Analyst Blog Highlights: AbbVie, Merck & Co. and AstraZeneca.NEWS5: Novartis (NVS) Q4 Earnings & Sales Top on Cosentyx, Entresto.NEWS6: Is a Beat in the Cards for AbbVie (ABBV) in Q4 Earnings?.NEWS7: 3 Stocks to Help You Build Retirement Wealth.NEWS8: The Zacks Analyst Blog Highlights: AbbVie, Merck & Co. and AstraZeneca.NEWS9: Novartis Announces Positive Results on Migraine Candidate.NEWS10: Will Core Segmental Growth Aid Stryker (SYK) in Q4 Earnings?.
2018-01-25: NEWS1: Will Pfizer (PFE) Surpass Estimates This Earnings Season?.NEWS2: Notable Thursday Option Activity: ASPS, ABBV, AMTD.NEWS3: Pre-Market Earnings Report for January 26, 2018 :  ABBV, HON, NEE, CL, APD, COL, LEA, GNTX, HRC, POL, NEP, ABCB.NEWS4: Will Pfizer (PFE) Surpass Estimates This Earnings Season?.NEWS5: Why AbbVie (ABBV) Might Surprise This Earnings Season.NEWS6: How Does Biogen Make its Money?.NEWS7: Why AbbVie (ABBV) Might Surprise This Earnings Season.NEWS8: See what the IHS Markit Score report has to say about AbbVie Inc..
2018-01-26: NEWS1: Intel and AbbVie jump while Starbucks and Colgate skid.NEWS2: [$$] AbbVie Says Tax Overhaul Will Slash 2018 Effective Tax Rate to 9%.NEWS3: What Happened in the Stock Market Today.NEWS4: The Hot Stock & Biggest Loser: AbbVie & Wynn Resorts.NEWS5: US STOCKS-Intel, healthcare shares boost lift Wall St to record.NEWS6: US STOCKS SNAPSHOT-Wall St climbs to new highs on strong Intel, AbbVie earnings.NEWS7: AbbVie Inc Stock Soars on Strong Q4 Earnings Beat.NEWS8: Here's Why AbbVie's Stock Is Skyrocketing 12.6% Today.NEWS9: This Is By Far the Most Important Number in AbbVie's Q4 Results.NEWS10: Here&apos;s Why AbbVie&apos;s Stock Is Skyrocketing 12.6% Today.NEWS11: 5 Biotech and Pharmaceutical Stocks Going Bonkers.NEWS12: How AbbVie Makes its Money.NEWS13: Blue-Chip Drug Stock, Dow Jones Name Boasts Big Yield, Hits 13-Year High.NEWS14: AbbVie (ABBV) Q4 Earnings Beat, 2018 View Raised, Shares Up.NEWS15: This Is By Far the Most Important Number in AbbVie&apos;s Q4 Results.NEWS16: AbbVie Needs to Plan for Harsher Post-Humira World.NEWS17: US Stocks Extend Gains as Health Care, Tech Sectors Edge Higher.NEWS18: Q4 GDP Sub-3%, Q4 Earnings Roll On.NEWS19: A Spate of Q4 Earnings.NEWS20: AbbVie (ABBV) Q4 Earnings Beat, 2018 View Raised, Shares Up.NEWS21: AbbVie Inc Stock Soars on Strong Q4 Earnings Beat.NEWS22: US STOCKS-S&P, Dow hit records on upbeat Intel, AbbVie earnings.NEWS23: AbbVie (ABBV) Q4 Earnings & Revenues Beat, Guidance Raised.NEWS24: S&P 500 Movers: CL, ABBV.NEWS25: Stocks Rally To New Record Closing Highs - U.S. Commentary.NEWS26: Stocks Rally To New Record Closing Highs - U.S. Commentary.NEWS27: Will J&J (JNJ) Witness Deceleration in 2018 Sales Growth?.NEWS28: Novartis Gets Spark Therapeutics' Luxterna License Outside US.NEWS29: Morning Movers: AbbVie Jumps on Earnings, Colgate Crushed, Gilead Rising.NEWS30: Don't Give Up on Gilead Yet.NEWS31: A Spate of Q4 Earnings.NEWS32: US STOCKS-Dow hits record on Intel earnings.NEWS33: AbbVie (ABBV) Q4 Earnings & Revenues Beat, Guidance Raised.NEWS34: Novartis Gets Spark Therapeutics&apos; Luxterna License Outside US.NEWS35: Will J&J (JNJ) Witness Deceleration in 2018 Sales Growth?.NEWS36: AbbVie shares rise 3% after Q4 profit, revenue beats, upbeat guidance.NEWS37: AbbVie’s Q4 Boosted by Strong Segment Results.NEWS38: Benzinga Pro's 6 Stocks To Watch Today.NEWS39: AbbVie beats Street 4Q forecasts.NEWS40: AbbVie's quarterly profit plunges on $1.14 bln tax charge.NEWS41: AbbVie Reports Full-Year and Fourth-Quarter 2017 Financial Results.NEWS42: 3 Promising Stocks to Buy in 2018.NEWS43: How Is Novartis’s Subsidiary Sandoz Positioned for 2018?.NEWS44: Stocks Hovering In Positive Territory In Mid-Day Trading - U.S. Commentary.NEWS45: Stocks Hovering In Positive Territory In Mid-Day Trading - U.S. Commentary.NEWS46: AbbVie (ABBV) Has Surged To A New High On Better Than Expected Q4 Earnings.NEWS47: AbbVie (ABBV) Has Surged To A New High On Better Than Expected Q4 Earnings.

Answer: Decrease